"Live long and prosper" -- with cancer? Biomira thinks it's possible. The biotechnology company is developing synthetic vaccines that trigger a patient's immune system to identify and fight cancer without the damaging effects of radiation or chemotherapy. Lead product candidate THERATOPE is a possible vaccine for metastic breast cancer that has received fast-track designation from the FDA. THERATOPE is also in clinical trials as a possible treatment for metastic colorectal cancer. The firm has teamed with Merck KGaA to develop BLP-25, a potential lung and prostate cancer vaccine.